Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04277637
Title Study of Bcl-2 Inhibitor BGB-11417 in Participants With Mature B-Cell Malignancies
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors BeiGene

marginal zone B-cell lymphoma

non-Hodgkin lymphoma

diffuse large B-cell lymphoma

follicular lymphoma

mantle cell lymphoma

chronic lymphocytic leukemia/small lymphocytic lymphoma

Waldenstroem's macroglobulinemia


BGB-11417 + Zanubrutinib


Age Groups: adult | senior
Covered Countries USA | ESP

No variant requirements are available.